The dominant signal is the near-exit of Wasatch Advisors, a significant active holder, which sold ~13.8M shares. Monitor for further institutional distribution in upcoming 13F filings and any insider buying to confirm a floor. The stock's low analyst bullishness (0% buy) and mixed cluster suggest continued downside risk absent a catalyst.
Executive Summary
Esperion Therapeutics (ESPR) saw a mixed institutional cluster in 2026-Q2: 6 buyers (net +$5.0M) led by JPMorgan doubling its stake, but 8 sellers (net -$48.4M) dominated by Wasatch Advisors exiting 87.8% of its position. The net selling pressure of ~$43.5M, concentrated in near-exit moves by large active managers, signals fading conviction despite modest accumulation by passive and smaller asset managers. The divergent insider activity (score 17/100, no open-market insider buying) weakens the buy-side signal.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$43.4M
▲ Buyers (6)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| JPMorgan | DOUBLED | +103.7% | $4.4M | $2.6M |
| Citigroup | DOUBLED | +187.6% | $1.2M | $848.0K |
| Bank Of New York Mellon | ADD | +32% | $2.3M | $794.0K |
▼ Sellers (8)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Wasatch Advisors | NEAR_EXIT | -87.8% | $43.2M | -$37.1M |
| Nuveen | NEAR_EXIT | -84.1% | $9.9M | -$8.1M |
| Deutsche Bank | NEAR_EXIT | -75.6% | $3.0M | -$2.2M |
Key Facts
- 6 institutional buyers added $5.0M in new positions, led by JPMorgan doubling to $4.4M
- 8 institutional sellers reduced holdings by $48.4M, led by Wasatch Advisors near-exiting a $43.2M position
- Net institutional outflow of ~$43.5M, with 5 of 8 sellers executing near-exit moves
- No open-market insider buying (confluence score 17/100, divergent)
- Top holders BlackRock ($70M) and State Street ($23M) did not materially change positions in this cluster
Financial Impact
Net institutional selling of approximately $43.5M, with Wasatch Advisors alone reducing by $37.1M (86% of total selling)
Risk Factors
- Wasatch Advisors' near-exit could signal fundamental concerns not yet public
- Low analyst conviction (0% buy) and no insider buying suggest limited support
- Institutional selling may accelerate if no positive catalyst emerges
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-ESPR-2026-Q2 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 29d ago | Court Ruling | — | awaiting T+5 | — | — |
Aug 13, 2026 7w ago | Institutional Cluster | — | awaiting T+5 | — | — |
Jul 23, 2026 10w ago | 15-12G | — | awaiting T+5 | — | — |
Jul 16, 2026 11w ago | EFFECT | $3.18 awaiting T+5 | awaiting T+5 | — | — |
Jul 16, 2026 11w ago | EFFECT | $3.18 awaiting T+5 | awaiting T+5 | — | — |
Jul 13, 2026 11w ago | 25-NSE | $3.19 awaiting T+5 | awaiting T+5 | — | — |
Jul 13, 2026 11w ago | 8-K | $3.19 awaiting T+5 | awaiting T+5 | — | — |
Jun 16, 2026 15w ago | DEFA14A | $3.17 $3.15 | ▼ −0.63% | ▲ +0.41% | — |
Jun 11, 2026 16w ago | Institutional Cluster | $3.15 $3.17 | ▲ +0.63% | ▲ +0.20% | — |
Jun 9, 2026 16w ago | 8-K | $3.14 $3.16 | ▲ +0.64% | ▼ −2.80% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access